Zhang Yujing, Wang Haiqian, Bai Lei, Li Xiaodong, Liu Li, Wang Liang
Department of Cardiovascular Surgery, General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China.
Department of Outpatient, General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China.
J Inflamm Res. 2024 Apr 17;17:2353-2363. doi: 10.2147/JIR.S450573. eCollection 2024.
To establish the endovascular repair and prognosis of patients with aorto-iliac aneurysm and infection.
From September 2018 to September 2021, seven cases of infection with aorto-iliac aneurysm were treated by the endovascular aneurysm repair (EVAR) procedure. Clinical and imaging data were collected to evaluate the therapeutic results, including body temperature, blood culture, imaging manifestations, stent patency and endoleak during the postoperative and follow-up periods.
Except for one patient who died of acute hematemesis and hematochezia just after the admission, seven patients were treated successfully. The aneurysms were completely excluded, and all stent grafts were patent. Patients were followed up for 12-32 months, with an average follow-up of 18.5 ± 9.1 months. There were no cases of endoleak, infection recurrence, gluteal muscle ischemia or spinal cord ischemia during the follow-up period.
It is feasible to treat -infected aneurysms with the EVAR procedure. The results were optimistic in the short and medium-term. The application of sensitive antibiotics before and after the operation is the cornerstone of endovascular therapy. However, the long-term results require further follow-up.
探讨腹主动脉-髂动脉瘤合并感染患者的血管腔内修复及预后情况。
选取2018年9月至2021年9月期间7例腹主动脉-髂动脉瘤合并感染患者，采用血管腔内动脉瘤修复术（EVAR）进行治疗。收集临床及影像学资料以评估治疗效果，包括术后及随访期间的体温、血培养、影像学表现、支架通畅情况及内漏情况。
除1例患者入院后因急性呕血、便血死亡外，其余7例患者均治疗成功。动脉瘤均被完全隔绝，所有支架型人工血管均通畅。患者随访12 - 32个月，平均随访时间为18.5±9.1个月。随访期间无内漏、感染复发、臀肌缺血或脊髓缺血等情况发生。
采用EVAR术治疗感染性动脉瘤是可行的，中短期效果乐观。手术前后应用敏感抗生素是血管腔内治疗的基石。然而，长期效果仍需进一步随访观察。
